Pulse lineResearch With Heart Logo

ARIC Publications

Filters: Keyword is Cystatin C  [Clear All Filters]
Mok Y, Ballew SH, Sang Y, Coresh JJ, Joshu CE, Platz EA. "Albuminuria, Kidney Function, and Cancer Risk in the Community." Am J Epidemiol. 2020;189(9):942-950.
Wong E, Ballew SH, Daya N, et al. "Hospitalization Risk among Older Adults with Chronic Kidney Disease." Am J Nephrol. 2019;50(3):212-220.
Inker LA, Coresh JJ, Sang Y, et al. "Filtration Markers as Predictors of ESRD and Mortality: Individual Participant Data Meta-Analysis." Clin J Am Soc Nephrol. 2017;12(1):69-78.
Ballew SH, Chen Y, Daya NR, et al. "Frailty, Kidney Function, and Polypharmacy: The Atherosclerosis Risk in Communities (ARIC) Study." Am J Kidney Dis. 2017;69(2):228-236.
Yang C, Kwak L, Ballew SH, et al. "Kidney function, bone-mineral metabolism markers, and future risk of peripheral artery disease." Atherosclerosis. 2017;267:167-174.
Agarwala A, Virani S, Couper DJ, et al. "Biomarkers and degree of atherosclerosis are independently associated with incident atherosclerotic cardiovascular disease in a primary prevention cohort: The ARIC study." Atherosclerosis. 2016;253:156-163.
van der Laan SW, Fall T, Soumaré A, et al. "Cystatin C and Cardiovascular Disease: A Mendelian Randomization Study." J Am Coll Cardiol. 2016;68(9):934-45.
Parrinello CM, Matsushita K, Woodward M, Wagenknecht LE, Coresh JJ. "Risk prediction of major complications in individuals with diabetes: the Atherosclerosis Risk in Communities Study." Diabetes Obes Metab. 2016;18(9):899-906.
Huang M, Matsushita K, Sang Y, Ballew SH, Astor BC. "Association of kidney function and albuminuria with prevalent and incident hypertension: the Atherosclerosis Risk in Communities (ARIC) study." Am J Kidney Dis. 2015;65(1):58-66.
Rebholz CM, Grams ME, Matsushita K, et al. "Change in Multiple Filtration Markers and Subsequent Risk of Cardiovascular Disease and Mortality." Clin J Am Soc Nephrol. 2015;10(6):941-8.
Rebholz CM, Grams ME, Matsushita K, Selvin E. "Change in novel filtration markers and risk of ESRD." Am J Kidney Dis. 2015;66(1):47-54.
Shlipak MG, Matsushita K, rnlöv JÄ, et al. "Cystatin C versus creatinine in determining risk based on kidney function." N Engl J Med. 2013;369(10):932-43.
Köttgen A, Pattaro C, Böger CA, et al. "New loci associated with kidney function and chronic kidney disease." Nat Genet. 2010;42(5):376-84.